Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 4 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Results 1 - 20 of 2145 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar Miketmah (57.79) Submitted: 4/16/2014 7:33:43 PM : Outperform Start Price: $98.69 JNJ Score: 0

A strong company in a tough market

Recs

0
Member Avatar pchop123 (78.31) Submitted: 4/16/2014 9:43:01 AM : Outperform Start Price: $99.33 JNJ Score: -1.01

nice PE & div yd combo for a great brand

Recs

0
Member Avatar MstCourtJester (28.24) Submitted: 4/15/2014 5:03:05 PM : Outperform Start Price: $99.57 JNJ Score: -1.11

Long, using the 10 ma as a stoploss.

Recs

0
Member Avatar TMFJoeFriday (34.09) Submitted: 3/24/2014 11:54:02 AM : Outperform Start Price: $94.84 JNJ Score: +3.60

A great dividend stock, bulletproof against negative headlines due to its massive diversity. P/E looks a little expensive for the company historically at the moment, but then again, so does the rest of the market. A great stable long-term performer, I think it can outperform the broader market.

Recs

0
Member Avatar moonlightsail (20.99) Submitted: 3/24/2014 6:15:30 AM : Outperform Start Price: $95.30 JNJ Score: +4.07

A defensive healthcare stock that has been around for a while and the dividend is good.

Recs

0
Member Avatar HayZeus (< 20) Submitted: 2/11/2014 4:37:30 PM : Outperform Start Price: $92.29 JNJ Score: +4.94

Band Aides Rule

Recs

0
Member Avatar rocker20 (48.15) Submitted: 2/11/2014 10:08:17 AM : Outperform Start Price: $91.11 JNJ Score: +5.38

Long history of dividends. Good products

Recs

0
Member Avatar ClimberMel (51.87) Submitted: 2/4/2014 11:21:08 AM : Outperform Start Price: $86.02 JNJ Score: +8.57

JNJ has always been a great performer. It has dropped much more than what I feel was justified. I've foolishly used this as a buying opportunity!

Recs

0
Member Avatar Golfer1 (26.95) Submitted: 2/3/2014 3:49:48 PM : Outperform Start Price: $86.19 JNJ Score: +7.79

Johnson and Johnson has taken a recent fall on the Stock Market, but will take a turn for the better and recover over the coming years with new and improved products.

Recs

0
Member Avatar kpruhs (< 20) Submitted: 12/20/2013 4:19:49 PM : Outperform Start Price: $91.90 JNJ Score: +5.50

JNJ has done so many things right for so many years that it will take more than a "great recession" to knock it out profitability. It falls in an elite class of companies that, while not invincible, will maintain market share, maintain reasonable dividends, and continue to fund R&D for expansion and growth.

While nothing in financial world is a sure-thing (AIG, Bear-Sterns, JPMorgan, etc.), in unsure financial times JNJ, PG, GE, MMM and their elite class of corporations are hard to bet against.

Recs

0
Member Avatar HealthyMoney (< 20) Submitted: 10/25/2013 12:12:18 PM : Outperform Start Price: $90.75 JNJ Score: +2.85

This conglomerate has diverse revenue streams, but will provide huge growth with its revamped pharmaceutical division.

Recs

0
Member Avatar BaseBawl (43.87) Submitted: 10/17/2013 2:57:01 PM : Outperform Start Price: $90.35 JNJ Score: +1.62

Dividend Growers.

Recs

0
Member Avatar rgofoolishdoc (51.19) Submitted: 10/9/2013 7:55:55 PM : Outperform Start Price: $85.50 JNJ Score: +4.32

Well diversified health care company will benefit from the ACA over the next 10 years

Recs

0
Member Avatar NickD (62.32) Submitted: 10/7/2013 10:55:12 AM : Outperform Start Price: $85.65 JNJ Score: +4.70

Good

Recs

0
Member Avatar izzy419 (64.87) Submitted: 9/21/2013 9:13:18 AM : Underperform Start Price: $88.18 JNJ Score: -2.90

ROA, RÔIC, ROE...all have a downward trend over the last 10 years. ROE from the mid 20's to the mid teens.
PE of 20 vs 18 for the SP500. JNJ IS the SP! Look like an underperform to me.

Recs

0
Member Avatar Coinmann (< 20) Submitted: 9/2/2013 8:33:02 PM : Outperform Start Price: $85.67 JNJ Score: +2.71

Great value.

Recs

0
Member Avatar mijoeash (< 20) Submitted: 8/3/2013 12:36:50 PM : Outperform Start Price: $91.48 JNJ Score: -1.11

Because every investor needs a rock to cling to. J & J is Gibraltar

Recs

0
Member Avatar Kingsx777 (38.23) Submitted: 7/29/2013 3:01:29 PM : Outperform Start Price: $91.35 JNJ Score: -2.19

Divendes

Recs

0
Member Avatar canapa124 (< 20) Submitted: 7/3/2013 2:01:05 PM : Outperform Start Price: $84.93 JNJ Score: +0.96

Steady flow of new products

Recs

0
Member Avatar NHWeston102 (81.52) Submitted: 6/20/2013 2:22:31 PM : Outperform Start Price: $81.29 JNJ Score: +5.47

JnJ has taken its lumps of late, but it is still a global company with a huge spectrum of well-known brands from baby-powder to band-aids. They are not afraid to buy pioneering companies to catch a leg up on the competition, but JnJ still retains a strong innovative edge of its own. Look, for example, at INVOCANA, a diabetes drug that controls glucose levels through urine stream rather than insulin regulation. A classic buy-and-hold blue chip that still has serious class!!

Featured Broker Partners


Advertisement